100 related articles for article (PubMed ID: 1918801)
21. Convenient method to purify hemoglobin.
Sakai H; Takeoka S; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):651-6. PubMed ID: 7994386
[TBL] [Abstract][Full Text] [Related]
22. [Purification and viral inactivation of hemoglobin from human placenta blood].
Li T; Zhang H; Wang H; Yu R; Yang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):640-4. PubMed ID: 16856406
[TBL] [Abstract][Full Text] [Related]
23. S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics.
Nakai K; Sakuma I; Togashi H; Yoshioka M; Sugawara T; Satoh H; Kitabatake A
Adv Exp Med Biol; 2003; 519():207-16. PubMed ID: 12675217
[No Abstract] [Full Text] [Related]
24. A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity.
Zolog O; Mot A; Deac F; Roman A; Fischer-Fodor E; Silaghi-Dumitrescu R
Protein J; 2011 Jan; 30(1):27-31. PubMed ID: 21161348
[TBL] [Abstract][Full Text] [Related]
25. [Effects of freeze-drying process on polymerized human placenta hemoglobin].
Zhao L; Li S; Li F; Wang J; Yang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Oct; 30(5):1052-7. PubMed ID: 24459969
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin-based oxygen-carrying solutions: close but still so far.
Levy JH
Anesthesiology; 2000 Mar; 92(3):639-41. PubMed ID: 10719939
[No Abstract] [Full Text] [Related]
27. Design of recombinant hemoglobins for use in transfusion fluids.
Fronticelli C; Koehler RC
Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
[TBL] [Abstract][Full Text] [Related]
28. Oxidized mono-, di-, tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes.
Eike JH; Palmer AF
Biotechnol Prog; 2004; 20(3):953-62. PubMed ID: 15176904
[TBL] [Abstract][Full Text] [Related]
29. Pilot-scale preparation of hemoglobin solutions.
Winslow RM; Chapman KW
Methods Enzymol; 1994; 231():3-16. PubMed ID: 8041260
[No Abstract] [Full Text] [Related]
30. Hemoglobin substitutes.
Klein HG
Clin Adv Hematol Oncol; 2008 Aug; 6(8):562-4. PubMed ID: 18820597
[No Abstract] [Full Text] [Related]
31. Processing of ferulic acid modified hemoglobin.
Guo S; Wang P; Chen C; Meng Z; Qi D; Wang X
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1075-9. PubMed ID: 26838267
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
Napolitano LM
Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
[TBL] [Abstract][Full Text] [Related]
33. Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.
Harrington JP; Gonzalez Y; Hirsch RE
Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):477-92. PubMed ID: 11063090
[TBL] [Abstract][Full Text] [Related]
34. Hemoglobin F Koelliker (alpha2 minus 141 (HC 3) Arg gamma2); a modification of fetal hemoglobin.
Kohne E; Krause M; Leupold D; Kleihauer E
Hemoglobin; 1977; 1(3):257-66. PubMed ID: 893128
[TBL] [Abstract][Full Text] [Related]
35. Effects of substitutions of lysine and aspartic acid for asparagine at beta 108 and of tryptophan for valine at alpha 96 on the structural and functional properties of human normal adult hemoglobin: roles of alpha 1 beta 1 and alpha 1 beta 2 subunit interfaces in the cooperative oxygenation process.
Tsai CH; Shen TJ; Ho NT; Ho C
Biochemistry; 1999 Jul; 38(27):8751-61. PubMed ID: 10393550
[TBL] [Abstract][Full Text] [Related]
36. Effect of NaBH4 concentration and reaction time on physical properties of glutaraldehyde-polymerized hemoglobin.
Eike JH; Palmer AF
Biotechnol Prog; 2004; 20(3):946-52. PubMed ID: 15176903
[TBL] [Abstract][Full Text] [Related]
37. Molecular dynamics of a hemoglobin crosslinking reaction.
Pavlik PA; Boyd MK; Olsen KW
Biopolymers; 1996 Oct; 39(4):615-8. PubMed ID: 8837523
[No Abstract] [Full Text] [Related]
38. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers.
McCarthy MR; Vandegriff KD; Winslow RM
Biophys Chem; 2001 Aug; 92(1-2):103-17. PubMed ID: 11527583
[TBL] [Abstract][Full Text] [Related]
39. Red cell substitutes from hemoglobin--do we start all over again?
Kluger R
Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
[TBL] [Abstract][Full Text] [Related]
40. Microvascular perspective of oxygen-carrying and -noncarrying blood substitutes.
Intaglietta M; Cabrales P; Tsai AG
Annu Rev Biomed Eng; 2006; 8():289-321. PubMed ID: 16834558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
